December 21, 2011 / 6:50 PM / 8 years ago

UPDATE 1-Merck gets approval for wider use of HIV drug

Dec 21 (Reuters) - U.S. health regulators have approved an expanded label for Merck & Co’s treatment for HIV for use with other antiretroviral drugs in children and adolescents.

The safety and effectiveness of the drug was evaluated in a clinical trial of 96 children and adolescents of ages 2-18 years with HIV-1 infection, the U.S. Food and Drug Administration said in a statement.

The drug, Isentress, was first approved for use in adult patients in October 2007.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below